Last Price
110.44
Today's Change
-0.21 (0.18%)
Day's Change
110.27 - 111.09
Trading Volume
1,297,941
Overview
Market Cap
61 Billion
Shares Outstanding
555 Million
Avg Volume
2,237,678
Avg Price (50 Days)
110.36
Avg Price (200 Days)
93.89
PE Ratio
16.41
EPS
6.73
Earnings Announcement
29-Jan-2025
Previous Close
110.65
Open
110.42
Day's Range
110.27 - 111.09
Year Range
75.08 - 115.5
Trading Volume
1,456,843
Price Change Highlight
1 Day Change
-0.19%
5 Day Change
1.95%
1 Month Change
-2.49%
3 Month Change
8.56%
6 Month Change
28.61%
Ytd Change
32.61%
1 Year Change
35.63%
3 Year Change
91.84%
5 Year Change
103.99%
10 Year Change
273.49%
Max Change
147153.33%
News and Blogs
No result.
Company Profile
Sector: Financial Services - Financial Services
Industry: Insurance—Life
Description:
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
2
3
CEO Morning Brief
FTX Sues Binance and Former CEO Zhao, Seeking US$1.8b Clawback
4
CEO Morning Brief
US Ordered TSMC to Halt Shipments of Chips for AI to China — Reuters
5
CEO Morning Brief
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
